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Abstract: Reduced migration capacity of trophoblast cells leads to poor placentation and correlates with severe pregnancy disorders
such as intrauterine growth restriction and preeclampsia. Neuropeptide Y (NPY) is sympathetic cotransmitter involved in various
physiological processes and its levels are significantly increased in preeclamptic pregnancy compared to healthy pregnancy. In this study
the prooxidative role of NPY and its effects on migration capacity of human trophoblast cell line JEG-3 were investigated together with
the effects of nitric oxide (NO) depletion, a molecule that was shown to play an important role in promoting cell migration. The cells
were treated for 24 h (short-term stimulation) and 72 h (long-term stimulation) respectively with 1 nM NPY. Oxidative/antioxidative
status and the migration index of cells were measured. The results showed increased concentrations of oxidative stress parameters (O2•–,
H2O2) and molecules of the antioxidant defense system (reduced glutathione and oxidized glutathione), while the levels of intracellular
nitrites (indicators of NO) and cell migration index were significantly decreased in trophoblast cells treated with NPY (both at 24 h
and 72 h of exposure) compared to the control cells. These results suggest that NPY may significantly contribute to reduced migration
capacity of trophoblast cells by generating oxidative stress and reducing the bioavailability of NO.
Key words: Neuropeptide Y, choriocarcinoma trophoblasts, oxidative stress, nitric oxide, migration

1. Introduction
The essential role in placentation belongs to trophoblast
cells, which arise from the outer layer of blastocysts
(Pennisi et al., 2012). The cytotrophoblast stem cells
undergo either the villous or the extravillous pathway of
differentiation. In the villous pathway, cytotrophoblasts
fuse to form multinucleated syncytiotrophoblasts
or aggregate to form anchoring villous trophoblasts,
which give rise to extravillous trophoblasts (Loke et al.,
1995). Villous trophoblasts cover the chorionic villi,
creating the placental–blood barrier, involved in gas
exchange and nutrient supply between the mother and
the fetus. Extravillous trophoblasts deeply invade the
uterine connective tissue, degrading the extracellular
matrix (interstitial route), and place themselves between
decidual and myometrial cells and then invade the uterine
spiral arteries (endovascular route) (Loke et al., 1995).
At this stage the extravillous trophoblasts remodel the
maternal spiral arteries, replacing smooth muscle and
endothelial cells forming vessels with a larger diameter,
and increase blood flow and reduce vascular resistance,
making these maternal vessels independent of maternal
vasoconstriction. This remodeling invasion is essential
* Correspondence: milosmatic@kg.ac.rs
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in establishing and developing the placenta as well as in
maintaining normal pregnancy, considering that the fetal
requirement for blood supply is much higher in the later
stages of pregnancy (Zhou et al., 1997). Since the process
strongly depends on an optimal trophoblast invasion of
the maternal tissue environment, failure of extravillous
trophoblasts to fully invade and modify the uterine tissue
leads to shallow placentation and is often associated with
serious pregnancy complications such as preeclampsia and
intrauterine growth restriction (Chaddha et al., 2004).
Neuropeptide Y (NPY) is a neuropeptide present in
significant levels in the peripheral and central nervous
systems and it has a role in various processes such as
anxiety, stress-related behaviors, food intake, digestion,
metabolism, immune response, memory, and learning
(Heilig, 2004; Ferreira et al., 2010; Farzi et al., 2015).
Literature data show that levels of NPY in patients with
preeclampsia and eclampsia, both caused by inadequate
placentation, are 2- to 4-fold higher than in women with
normal pregnancies (Khatun et al., 2000).
The production of reactive oxygen species is a
physiological process inherent to aerobic organisms due
to mitochondrial respiratory chain activity and phagocytic
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actions (Nazıroğlu et al., 2015). Oxidative stress represents
an imbalance between the production of reactive oxygen
species and the compensating antioxidant mechanisms,
which can lead to multiple cellular damages (Li et al.,
2013).
Nitric oxide (NO) is a multifunctional signal molecule
and has been reported as a mediator of many physiological
and pathological processes in a variety of tissues, including
those involved in human reproduction. NO is one of the
most pleiotropic signaling molecules at systemic and
cellular levels, participating in vascular tone regulation,
cellular respiration, proliferation, apoptosis, and gene
expression (Krause et al., 2011). Nitric oxide is generated
from L-arginine by the enzyme nitric oxide synthase
(NOS). Two of the three known isoforms of NOS are
constitutively expressed in different cell types (NOS1 or
neuronal; NOS3 or endothelial NOS - eNOS), whereas
the expression of the third isoform (NOS2 or inducible
NOS - iNOS) can be induced with cytokines and other
agents (Moncada et al., 1991). Both iNOS and eNOS are
present in human trophoblasts (Rossmanith et al., 1999;
Hambartsoumian et al., 2001). The quantification of NO
metabolites (like nitrites and nitrates) in biological samples
provides valuable information with regard to in vivo NO
production, bioavailability, and metabolism (Bryan et al.,
2007). The production of NO by iNOS in the myometrium
and placenta increases throughout pregnancy until
delivery, when it decreases rapidly (Von Mandach et
al., 2003). One of the main roles of NO increase during
pregnancy is to stimulate vasodilatation and to increase
blood flow subsequently (Benest et al., 2008). Nitric oxide
activates protein kinase G (PKG), which phosphorylates
multiple protein substrates including integrins and cell
adhesion molecules. NO-dependent phosphorylation
induces conformational changes of the integrins, altering
their ligand-binding affinity, which affects cell motility
(Cartwright and Balarajah, 2005; Chigaev et al., 2011).
It was shown in mice and rats that the stimulation
of macrophages with NPY increased the production of
reactive oxygen species such as peroxide and superoxide
(De la Fuente et al., 2001; Dimitrijevic et al., 2005) and that
these effects are mediated via Y1 and Y2 receptors (Bedoui
et al., 2008). By stimulating the generation of these reactive
oxygen molecules, which can alter levels of free NO (Jaimes
et al., 2001; Hsieh et al., 2014), NPY could be an important
factor in depletion of cell migration dependent on NOmediated pathways. In this study we investigated the
modulatory capacity of NPY on the mobility of a human
choriocarcinoma cytotrophoblastic cell line by examining
its effects on the oxidative/antioxidative balance and
bioavailability of NO.

2. Materials and methods
2.1. Cell culture and treatment
The cytotrophoblastic human choriocarcinoma cell line
JEG-3, purchased from the American Type Culture
Collection, was used in this study. The cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM, GIBCO)
supplemented with heat-inactivated 10% fetal bovine
serum (FBS), penicillin, and streptomycin (GIBCO). The
cells were grown to 80% confluence in 75-cm2 flasks at
37 °C in a normal atmosphere containing 5% CO2. This
cell line is easy to culture and represents a convenient
model for cell migration. NPY concentrations of 1 nM, 10
nM, and 100 nM were tested for cytotoxicity. In order to
investigate the effects of NPY on oxidative/antioxidative
status and cell migration capacity, 1 nM NPY was used
as treatment. The stock solution of NPY was prepared in
phosphate-buffered saline (PBS) and then the NPY stock
was serially diluted in DMEM to final concentrations of 1
nM, 10 nM, and 100 nM. The control cells were cultured
in conditioned medium only (DMEM) to acquire the basal
levels of oxidative stress parameters and migration index.
2.2. MTT assay
The cells were seeded into a 96-well plate (10,000 cells per
well) and incubated at 37 °C and 5% CO2 for 24 h. The
medium was replaced with 100 µL of medium containing
various concentrations of NPY (1 nM, 10 nM, and 100
nM) and cells were incubated for 24 h. Untreated cells were
used as the control. After 24 h of NPY treatment, the cell
viability was determined by MTT assay (Mosmann, 1983).
The test was based on the color reaction of mitochondrial
dehydrogenase in living cells by MTT. At the end of the
treatment period, MTT (final concentration: 5 mg/mL
of phosphate buffer solution) was added to each well,
which were then incubated at 37 °C in 5% CO2 for 3 h.
The colored crystals of produced formazan were dissolved
in 150 µL of DMSO. The absorbance was measured by a
microplate reader. The cell viability was calculated as a
ratio of absorbance of the treated group divided by the
absorbance of the control group and multiplied by 100 to
give a percentage of viability.
2.3. Transwell assay for cell migration
The cell migration capacity was determined by the ability
of cells to cross the pores of polycarbonate membranes
(pore size 8 µm; Greiner Bio-One, Switzerland) fitted to
the bottom of transwell chambers. The migration test was
based on a protocol described by Chen (2005). The cells
were exposed to 1 nM NPY for 24 h and 72 h, respectively.
In another set of experiments the cells were incubated
with 1 mM NG-nitro-L-arginine methyl ester (L-NAME)
for 24 h and 72 h. The initial solution of L-NAME in
PBS was used for the study and then the solution was
diluted in conditioned medium (DMEM) to acquire the
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1 mM concentration. The control cells were cultured
only in conditioned medium (DMEM, GIBCO). Each
measurement was performed in triplicate (3 wells for each
experimental cell group). After the exposures, all three
groups of cells were trypsinized and placed in the upper
chambers at a density of 1 × 105 cells/well in 500 µL of
DMEM with 10% FBS. The lower chambers of the control
cells contained 750 µL of DMEM supplemented with 10%
FBS whereas the lower chambers with treated cells were
filled with 1 nM NPY or 1 mM L-NAME diluted in 750
µL of DMEM supplemented with 10% FBS. After 6 h of
incubation at 37 °C, the cells from the upper surface of
the filter were completely removed with gentle swabbing.
The remaining migrated cells were fixed for 20 min at
room temperature in 4% paraformaldehyde and stained
with 0.1% crystal violet in 200 mM 2-(N-morpholino)
ethanesulfonic acid (pH 6.0) for 10 min. After adding
10% acetic acid, absorbance was measured by an ELISA
microplate reader. The migration index was calculated as
the ratio of absorbance of the treated group divided by the
absorbance of the control and multiplied by 100 to give the
percentage.
2.4. Cell extraction
After 24 h or 72 h of NPY treatment, cells were trypsinized,
transferred from each flask into a separate test tube, and
centrifuged for 10 min at 1000 × g and 4 °C in order to
remove the culture medium (discarded supernatant).
The cells were washed with ice-cold PBS (GIBCO), and
after recentrifugation (10 min, 1000 × g, 4 °C) they were
resuspended in a volume of PBS in which the number of
cells was 106/mL. This cell suspension was used for further
analysis.
2.5. The determination of superoxide anion (O2•–)
NPY-treated cells adjusted to 1 × 106 cells/mL in PBS were
plated at 100 µL/well in a 96-well flat-bottomed plate and
mixed with 100 µL of 0.1% nitro blue tetrazolium (NBT).
The determination of superoxide anion (O2•–) was based
on the reduction of NBT in the presence of O2•– (Auclair
and Voisin, 1985). The concentration was expressed as
nmol/L in 106 cells/mL.
2.6. NO2− and H2O2 determination
To determine the concentration of NO2− and H2O2,
cell membranes were broken by sonication of the cell
suspension on ice with a series of 10 successive acoustic
shocks. The samples were then centrifuged for 20 min at
10,000 × g and 4 °C. The concentrations of nitrites and
hydrogen peroxide were determined in the supernatant.
The determinations of nitrites (NO2−, indicator of NO
concentration) were performed using the Griess method
(Green et al., 1982). The determination of the hydrogen
peroxide (H2O2) concentration was based on oxidation of
phenol red in the presence of horseradish peroxidase as
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a catalyst (Pick and Keisari, 1980). The concentrations of
both parameters were determined by ELISA microplate
reader. The concentrations of NO2− were expressed as
µmol/L in 106 cells, while the levels of H2O2 were expressed
as nmol/L in 106 cells/mL.
2.7. Glutathione determination
For measuring the concentrations of reduced glutathione
(GSH) and oxidized glutathione (GSSG), the used
supernatant was obtained by the following procedure:
the cell suspension was centrifuged for 10 min at 1000
× g and 4 °C, and after the removal of supernatant, the
pellet was resuspended in 2.25% sulfosalicylic acid. Cell
membranes were lysed by alternate freezing (‒80 °C)
and thawing (37 °C) in 3 cycles for 15 min followed by
30 min of centrifugation at 1000 × g. The concentration
of GSH was determined based on GSH oxidation with
5.5-dithiobis-6.2-nitrobenzoic acid (Beutler, 1975). The
concentration of GSSG was determined based on GSH
determination assay using glutathione reductase (Beutler,
1975) after inhibition of spontaneous GSH oxidation by
4-vinylpyridine. Glutathione concentration was expressed
as µmol/L in 106 cells/mL.
2.8. Statistical analysis
All groups of data were analyzed with SPSS 13.0 for
Windows. The results are presented as the mean ± SEM
using the independent t-test to evaluate significant
differences between experimental groups versus the
control group. Probability values of less than 0.05 were
considered significant.
3. Results
3.1. MTT viability assay
For the assessment of the appropriate concentration of NPY
to be used for the treatment, the effect of this peptide on
cytotrophoblast cell viability was examined. To investigate
the acute effects of NPY on oxidative stress parameters and
migration capacity, the highest noncytotoxic concentration
of NPY was used in our study. The results of the MTT
test showed that only the concentration of 1 nM was not
cytotoxic for the JEG-3 cell line (more than 95% of cells
survived). The higher tested concentrations of NPY (10
nM and 100 nM) significantly caused the decrease of the
number of living cells (Figure 1).
3.2. Concentrations of oxidative/antioxidative status
parameters (O2•−, H2O2, and NO2−)
The concentrations of oxidative stress parameters after
exposure to 1 nM NPY were measured in our experiment.
The results showed that the concentrations of O2•– and H2O2
were significantly increased in cells treated with NPY for
both 24 h and 72 h compared to the control cells (P < 0.05)
(Figure 2). In this study the concentrations of NO2− (the
indicator of NO) after 1 nM NPY treatment of trophoblast
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Figure 1. The results of MTT viability assay of human
choriocarcinoma cell line JEG-3 exposed to various concentrations of
NPY. Data are representative of three independent experiments and
values are expressed as mean ± SEM. *: Statistically significant
compared to the control group (P < 0.05).

cells were also examined. The results showed that NPY
induced significant decrease in the concentrations of NO2−
in the cells treated with NPY for 24 h and even stronger
decrease in long-term (72 h) treatment as compared to
control cells (P < 0.05) (Figure 2).
.-
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3.3. Concentrations of antioxidant defense system
parameters (GSH and GSSG)
The concentrations of GSH in cells treated with NPY both
for 24 h and 72 h were significantly increased compared
to control cells (P < 0.05) (Figure 3). Glutathione is one of
the strongest antioxidative components and its increased
concentration may indicate de novo synthesis induced
by NPY. No significant changes in the concentration of
GSSG were recorded in the cells treated with NPY for 24
h compared to the control cells (Figure 3), which could
indicate the initial high activity of glutathione reductase
(GR) as one of the major enzymes of the antioxidant
defense system in trophoblasts. However, the GSSG level
in cells treated with NPY for 72 h was significantly elevated
compared to control cells (Figure 3).
3.4. Transwell migration assay (Boyden chamber assay)
To examine the effects of NPY on the migration capacity
of a human trophoblast cell line, a transwell migration
assay was performed. Results showed 1.38-fold and 1.58fold decrease in the cell migration index of JEG-3 cells
exposed to NPY for 24 h and 72 h, respectively, compared
to the control cells. Long-term exposure to NPY induced
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Figure 2. The effects of short-term (24 h) and long-term (72 h) exposure to NPY on parameters of oxidative/antioxidative status in
human choriocarcinoma cell line JEG-3. Data are representative of three independent experiments and values are expressed as mean ±
SEM. *: Statistically significant compared to the control group (P < 0.05).
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Figure 3. The effects of short-term (24 h) and long-term (72 h) exposure to NPY on reduced glutathione (GSH) and oxidized glutathione
(GSSG) levels in human choriocarcinoma cell line JEG-3. Data are representative of three independent experiments and values are
expressed as mean ± SEM. *: Statistically significant compared to the control group (P < 0.05).

stronger reduction of trophoblast migration compared to
24 h of treatment. These data indicate that treatment with
1 nM NPY significantly reduced the migratory capacity
of human choriocarcinoma trophoblast cells (Figure 4).
We proposed that NPY-induced reduction of migration
capacity was related to a decrease in NO concentration
during NPY treatment, so we exposed cells to 1 mM
L-NAME (NOS inhibitor) for 24 h and 72 h. Our results
showed 2.36-fold decrease in cell migration index in cells

treated with L-NAME for 24 h and 2.14-fold decrease in
cells treated with L-NAME for 72 h as compared to control
cells (Figure 5). By comparing the migration index of the
cells between NPY treatment and L-NAME treatment we
could conclude that there was 1.76-fold decrease in cell
migration index between short-term NPY and L-NAME
exposures (24 h) (Figure 6a) and 1.36-fold decrease in cell
migration index between long-term NPY and L-NAME
exposures (72 h) (Figure 6b). These data indicate that
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Figure 4. The effects of short-term (24 h) and long-term
(72 h) exposure to NPY on migration capacity of human
choriocarcinoma cell line JEG-3. Data are representative of three
independent experiments and values are expressed as mean ±
SEM. *: Statistically significant compared to the control group
(P < 0.05).
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Figure 5. The effects of short-term (24 h) and long-term (72
h) exposure to L-NAME on migration capacity of human
choriocarcinoma cell line JEG-3. Data are representative of three
independent experiments and values are expressed as mean ±
SEM. *: Statistically significant compared to the control group
(P < 0.05).
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Figure 6. The ratio between the effects on migration capacity of human choriocarcinoma cell line JEG-3 of short-term (24 h) and
long-term (72 h) exposure of these cells to 1 nM NPY and 1 mM L-NAME, respectively. Data are representative of three independent
experiments and values are expressed as mean ± SEM. *: Statistically significant compared to the control group (P < 0.05).

NO depletion by L-NAME, and to a lesser extent by
NPY, is responsible for decreased cell migration capacity.
Together, these results suggest that reduced migration of
human trophoblast cell line JEG-3 could be mediated by
decreased levels of NO.
4. Discussion
Trophoblast migration is an essential step in successful
implantation and formation of the placenta (Pijnenborg
et al., 1983; Knöfler and Pollheimer, 2013). Khatun et
al. (2000) showed that high concentrations of NPY may
contribute to the development of preeclampsia, which
is characterized by shallow trophoblast invasion. We
proposed that NPY, regarding its increased level in
preeclampsia, could be one of the factors that affect the
migratory capacity of trophoblast cells by inducing
oxidative stress. Various studies reported signal pathways
that can affect the oxidative/antioxidative balance in cells.
NPY has been shown to trigger the phospholipase C-protein
kinase C (PLC-PKC) pathway, activating nicotinamide
adenine dinucleotide phosphate oxidase (NADPH
oxidase) via its receptors in human syncytiotrophoblasts
and hamster suprachiasmatic nuclei cells (Robidoux et al.,
1998; Schak et al., 2001). NADPH oxidase is an important
respiratory chain enzyme and represents the main source
of superoxide anion radical (O2•–) in neutrophils, vascular
endothelial cells, smooth muscle cells, and trophoblasts
(Griendling et al., 2000; Halliwell and Gutteridge, 2007).
So far, the Y1 and Y3 receptors for this peptide have been
described in human trophoblasts as a mixed population
(Robidoux et al., 1998, 2000). Prooxidative effects of

neuropeptide Y mediated via Y1 and Y2 receptors were
recorded in macrophages (Dimitrijevic et al., 2005; Bedoui
et al., 2008), suggesting that elevated levels of reactive
oxygen species in trophoblasts exposed to NPY could be
caused by the elevated activity of NADPH oxidase in these
cells. However, the possible activity alterations of NADPH
oxidase induced by NPY exposure in trophoblasts are yet
to be determined.
In this study we measured both the levels of reduced
glutathione (GSH) and oxidized glutathione (GSSG).
Although these molecules might not directly interfere
with nitric oxide, they are accepted as important
markers of the oxidative/antioxidative status of the cell.
Glutathione levels were measured in order to elucidate
the intensity of oxidative stress induced by neuropeptide
Y in trophoblasts, and to examine some antioxidative
performances of these cells as well. The results showed
increased levels of glutathione in both NPY treatments
(24 h and 72 h). Reduced glutathione, a tripeptide
consisting of cysteine, glutamate, and glycine, is one of the
strongest antioxidative components in cells, maintaining
intracellular thiol status and detoxicating various
metabolites, essential for optimal activity of some enzymes
and other cellular macromolecules (Chung et al., 2016).
Since GSH is a potent electron donor, it represents the
major nonenzymatic antioxidant component and one of
the most important scavengers of free radicals, converting
itself to the oxidized dimeric form, GSSG (Jones, 2002).
Increased concentrations of reduced glutathione (GSH)
recorded in our experiment suggest de novo synthesis
of GSH induced by NPY. GSH is synthesized in cells de
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novo and rapid induction of intracellular GSH synthesis
occurs in response to various stressors (Kondo et al.,
1993; Shi et al., 1994). Oxidative stress has been shown
to induce transcriptional upregulation of the enzyme in
the GSH biosynthesis pathway, γ GCS-gamma-glutamylcysteine synthetase (Rahman and MacNee, 1999; Ray et
al., 2002). The cell culture medium (DMEM) contains
a significant amount of cystine, which is one of the
components used in GSH biosynthesis. Our results show
the elevated levels of glutathione (GSH), which might
be caused by de novo synthesis. The increased activity
of GSH biosynthesis enzymes could be due to the high
concentrations of reactive oxygen species generated in
trophoblasts by NPY. Elevated GSH levels appear to be an
important defense mechanism in human cytotrophoblasts
in response to aggressive oxidative stress radicals induced
by NPY. An increase in GSSG levels and reduction of
the GSH/GSSG ratio indicates glutathione antioxidative
activity in response to oxidative stress, which could lead to
numerous cell damages (Lu, 2009). No significant changes
in the concentrations of GSSG were recorded in cells
treated with NPY for 24 h compared to the control cells
(Figure 3), which could indicate the initial high activity of
glutathione reductase (GR) as one of the major enzymes
of the antioxidant defense system in trophoblasts. Since
trophoblasts have stem cell features, the basal antioxidative
activity of these cells may be higher compared to the other
highly differentiated cell types (Aplin et al., 1999; Baczyk et
al., 2006; Shenghui et al., 2009; Kobayashi and Suda, 2012).
However, after long-term NPY exposure, trophoblast cells
express increased levels of oxidized glutathione (GSSG).
This elevation might be caused by prolonged production
of reactive oxygen species generated by long-term NPY
exposure, exceeding the reductive capacity of the GR
enzyme and leading to accumulation of GSSG. The activity
of GR and other antioxidant defense enzymes in JEG-3
cells is yet to be determined. Our results indicate the high
basic antioxidant potential of trophoblasts, which could
mean that NPY has the ability to generate an abundant
burst of reactive oxygen species in trophoblast cells. The
increased levels of H2O2 and O2•– during NPY exposure
demonstrated in our study suggest that this peptide is a
significant inducer of oxidative stress in this cell line.
In human trophoblasts both iNOS and eNOS are
present, so these cells synthesize NO (Rossmanith et al.,
1999; Hambartsoumian et al., 2001). Various actions of
nitric oxide are known to contribute to the maintenance
of pregnancy. Numerous data show that oxidative stress
contributes to altered NO bioavailability (Pandey and Rizvi,
2010; Prokić et al., 2015). Superoxide anion radical, when
produced in high concentrations, scavenges nitric oxide
and forms cytotoxic peroxynitrite (ONOO−) (Jourd’heuil
et al., 2001; Calabrese et al., 2007). Not only does the
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superoxide anion radical oxidize lipids and proteins in
cell membranes and cytoplasm, but the formation of
peroxynitrites also results in reduced NO bioavailability,
affecting NO-mediated pathways. Nitric oxide has been
shown to affect cell migration and invasion in a variety
of cell types (Murohara et al., 1999; Giordano et al., 2006;
Li et al., 2009). In vitro studies showed that motility and
invasion of trophoblast cells also depend on trophoblastderived NOS (Cartwright et al., 1999; Harris et al., 2008).
Nitric oxide has significant roles in cell migration via
regulation of integrin phosphorylation (Chigaev et al.,
2011). NO appears to be involved in the regulation of the
phosphorylated state of two adhesion molecules, VCAM1 (vascular cell adhesion molecule-1) and α4β1 integrin.
These adhesion molecules are important in trophoblast
interaction with endothelial cells in uterine arteries and
their ligand binding affinity depends on phosphorylation
performed by NO-dependent protein kinase G
(Cartwright and Balarajah, 2005). In this study, the effects
of NO depletion in the JEG-3 cell line on cell migration
capacity were examined by treating the cells with 1 mM
L-NAME, which is the inhibitor of NOS enzymes. Our
data showed over 2-fold decrease in migration capacity
(Figure 5), suggesting the essential role of nitric oxide
in the migration mechanisms of these cells. The results
obtained in a study by Harris et al. suggest that nitric oxide
could also promote trophoblast invasion by mechanisms
other than phosphorylation; S-nitrosylation of proteins at
the leading edge of trophoblasts contributes to the elevated
migration of these cells (Harris et al., 2008). The results of
our experiment show that NPY treatment increased O2•–
and decreased NO levels, suggesting that the formation of
peroxynitrite (ONOO−) is one of the possible mechanisms
of reducing NO bioavailability in JEG-3 cells, contributing
to the reduction of NO-dependent migration capacity.
Moreover, regarding the presence of NO-producing
enzymes (eNOS and particularly iNOS) in human
trophoblasts (Rossmanith et al., 1999; Hambartsoumian et
al., 2001), we assume that long-term (72 h) NPY treatment
might affect expression patterns of these enzymes.
Stronger reduction in NO bioavailability, as well as more
severe reduction of migration capacity recorded in longterm NPY-treated cells in comparison to short-term NPY
treatment, could be caused by prolonged production of
reactive oxygen species (especially O2•–) and/or by changes
in expression levels of NO-generating enzymes. In further
research, we plan to investigate mRNA levels and protein
quantification of iNOS in long-term NPY treatment of the
same cell line.
Although the majority of studies have reported invasionpromoting effects of NPY on various cell types (Ruscica et
al., 2007; Sheriff et al., 2010), there are a number of data
that indicate its antimigratory and antiproliferative effects.
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NPY administration to a variety of invasive cancers results
in reduced invasive potential and/or decreased proliferation
of cells of these tumors in a concentration-dependent
manner. NPY administration to a number of prostate
cancer cell lines inhibited the proliferation through an
NPYR1-dependent mechanism, while NPY administration
to cholangiocarcinoma cells in vitro reduced the invasion
potential of these tumor cells in a concentration-dependent
manner (Ogasawara et al., 1997; DeMorrow et al., 2011).
One study indicated NPY as an inhibitor of migration of
monocytes to the tissue (Nave et al., 2004). The results of
our investigation also indicate an antimigratory role of NPY
on human cytotrophoblast cells.
According to the results we conclude that NPY
induces oxidative stress in human trophoblast cell line
JEG-3 by stimulating increased production of oxygen
reactive species such as O2•– and H2O2 both in shortterm (24 h) and long-term (72 h) treatments. The levels
of GSH, as one of the main antioxidative components in
trophoblasts, are increased probably due to its elevated de
novo biosynthesis in response to NPY exposure, which
implies considerable basal antioxidative capacity of human
trophoblasts. Nevertheless, the increased levels of oxidized
glutathione (GSSG) after long-term NPY exposure may
suggest that NPY is a significant generator of oxidative
stress, which can surpass the inherent trophoblast
antioxidative capacity. The concentrations of nitric oxide
are significantly decreased in trophoblasts exposed to
NPY for both 24 h and 72 h of treatment compared to
the control cells, as well as the migratory capacity of
trophoblasts, with more severe reduction during longterm (72 h) exposure. Based on these data, we proposed

that 24 h and 72 h of NPY treatment reduced the migratory
potential of human choriocarcinoma trophoblast cells by
reducing the bioavailability of NO. The short-term and
long-term treatments with a specific inhibitor of NOS
enzymes (L-NAME) reduced the migration index of these
cells. Accordingly, we assume that this motility reduction
is caused by depleted bioavailability of NO, which affects
NO-dependent migration pathways. NO is involved in
the regulation of the function of cell adhesion molecules,
presumably the integrins, important for cell motility. Since
NO reduction is mediated by superoxide anion radical
scavenging of free nitric oxide and possibly by altering
the activities and expression patterns of NO-generating
enzymes, we assume that NPY is responsible for depleted
migration capacity of human trophoblasts by generating
considerable oxidative stress in these cells. In future
studies, we plan to examine the effects of NPY on the other
antioxidant defense system components in trophoblasts,
as well as on the expression patterns and activities of
oxidative stress generating enzymes, such as NADPH
oxidase. Furthermore, the impact of NPY on the activities
and expressions of iNOS enzymes, and on the expression
and distribution of both adhesion and invasion proteins,
will be examined as well. These data should contribute
to a better understanding of underlying mechanisms of
placental disorders.
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